Dose Biosystems is Biotechnology in Canada that focus on consumer feasibility testing business. Founded in 2020. They cover business area such as developer, next-generation probiotic, consumer, their microbiome, discovery, utilization, large metagenomic dataset, pathway, improved delivery mechanism, development, encapsulation technology, regulatory assessment, validation, new product, microbiome literacy, more choice.
2020
( 4 years old in 2024 )
Consumer Feasibility Testing
-
1300-61 University Avenue
Toronto, Ontario M5G 0B7
Canada
Private
developernext-generation probioticconsumertheir microbiomediscoveryutilizationlarge metagenomic datasetpathwayimproved delivery mechanismdevelopmentencapsulation technologyregulatory assessmentvalidationnew productmicrobiome literacymore choice
* We use standard office opening hours in near Dose Biosystems's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Dose Biosystems is Biotechnology business from Canada that founded in 2020 (4 years old in 2024), Dose Biosystems business is focusing on Consumer Feasibility Testing.
Dose Biosystems headquarter office and corporate office address is located in 1300-61 University Avenue Toronto, Ontario M5G 0B7 Canada.
Dose Biosystems was founded in Canada.
In 2024, Dose Biosystems is currently focus on consumer feasibility testing sector.
Above is snippet of Google Trends for "consumer feasibility testing" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Dose Biosystems, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
